EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Insulin-like growth factor-binding protein 3 and incidence of pancreatic cancer in a nested case-control study

Yasushi Adachi iD, Masanori Nojima, Yingsong Lin iD, Yoshiharu Masaki, Yasushi Sasaki, Hiroshi Nakase iD, Kenji Wakai, Mitsuru Mori, Akiko Tamakoshi, For JACC study

Japanese Journal of Clinical Oncology · 2025

DOI: 10.1093/jjco/hyaf146 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Yasushi Adachi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Sapporo Medical University, S-1, W-16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor I, Biomarkers, Tumor. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Grants-in-Aid for Scientific Research on Priority Areas of Cancer, Scientific Research on Priority Areas of Cancer Epidemiology from MEXT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin-like growth factors (IGFs) are potent mitogens and IGF-binding protein 3 (IGFBP3) can regulate IGF activity. To elucidate relationships between IGF-related molecules and risk of pancreatic cancer, we analyzed associations between serum levels of IGF1 and IGFBP3 and incidence of pancreatic cancer in a prospective, nested, case-control study within the Japan Collaborative Cohort study.

Methods

A baseline survey was conducted from 1988 to 1990, during which period blood samples were obtained from 39 242 subjects. Subjects who had been diagnosed with pancreatic cancer by 1997 were regarded as cases. Conditional logistic regression was used to estimate odds ratios (ORs) for the incidence of pancreatic cancer in relation to serum levels of IGF1 and IGFBP3.

Results

This analysis included 72 cases and 216 controls. Free IGFBP3 (estimated as IGFBP3–IGF1) was associated with the risk of pancreatic cancer (P for trends = 0.011), with the third tertile showing the highest risk (OR = 3.42, 95%CI = 1.31–8.91). None of total IGF1, free IGF1 (estimated as IGF1/IGFBP3), or total IGFBP3 were associated with risk of pancreatic cancer. This result remained unchanged in subanalyses of male, female, and older subjects (P for trends = 0.017, 0.030, and 0.007, respectively). When limiting analysis to participants followed for over 2 years, free IGFBP3 was associated with risk of pancreatic cancer (P for trends = 0.025).

Conclusions

Our findings suggest that free IGFBP3 is associated with the risk of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IBiomarkers, TumorHumansFemaleMaleCase-Control StudiesMiddle AgedAgedIncidenceJapanProspective StudiesRisk FactorsOdds RatioLogistic ModelsAdultInsulin-Like Peptides

Stichwörter der Autor:innen

IGF binding proteininsulin-like growth factonested case-control studyodds ratiopancreatic cancer

Substanzen

Insulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IBiomarkers, TumorIGF1 protein, humanIGFBP3 protein, humanInsulin-Like Peptides

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Sapporo Medical University, S-1, W-16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan.
  • Division of Gastroenterology, Department of Internal Medicine, Sapporo Shirakaba-dai Hospital, 7-26, 18 Choume, Tsukisamu Higashi 2 Jo, Toyohira-ku, Sapporo, Hokkaido 062-0052, Japan.
  • The Institute of Medical Science Hospital, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
  • Department of Public Health, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan.
  • Department of Preventive Medicine, Nagoya University, Graduate School of Medicine, 65 Tsurumaicho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • Hokkaido Chitose College of Rehabilitation, 10, Satomi 2 chome, Chitose, Hokkaido 066-0055, Japan.

ORCID-Profile: Yasushi Adachi, Yingsong Lin, Hiroshi Nakase

Förderung

  • Grants-in-Aid for Scientific Research on Priority Areas of Cancer
  • Scientific Research on Priority Areas of Cancer Epidemiology from MEXT

Zitieren

APA

Adachi, Y., Nojima, M., Lin, Y., Masaki, Y., Sasaki, Y., Nakase, H., Wakai, K., Mori, M., Tamakoshi, A., & For JACC study (2025). Insulin-like growth factor-binding protein 3 and incidence of pancreatic cancer in a nested case-control study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf146

Vancouver

Adachi Y, Nojima M, Lin Y, Masaki Y, Sasaki Y, Nakase H, et al. Insulin-like growth factor-binding protein 3 and incidence of pancreatic cancer in a nested case-control study. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyaf146

BibTeX
@article{Adachi2025,
  author = {Adachi, Yasushi and Nojima, Masanori and Lin, Yingsong and Masaki, Yoshiharu and Sasaki, Yasushi and Nakase, Hiroshi and Wakai, Kenji and Mori, Mitsuru and Tamakoshi, Akiko and For JACC study, For JACC study},
  title = {Insulin-like growth factor-binding protein 3 and incidence of pancreatic cancer in a nested case-control study},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1093/jjco/hyaf146}
}
Kostenlos starten →